Virbac SACA

Virbac : Public release of Virbac Annual Report at 31 December 2023 (ESEF format)

24 Apr 2024 12:00:00 By Nasdaq GlobeNewswire

VIRBAC: Building on the momentum of the second half of 2023, strong first-quarter revenue growth of +10.8% at constant exchange rates

16 Apr 2024 11:45:00 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 03/2024

09 Apr 2024 08:46:42 By Nasdaq GlobeNewswire

Virbac acquired Sasaeah, a leading animal health player in Japan

02 Apr 2024 11:45:00 By Nasdaq GlobeNewswire

Virbac: Public Release of the Year-End Consolidated Accounts at 31 December 2023

19 Mar 2024 13:00:00 By Nasdaq GlobeNewswire

VIRBAC: 2023 ANNUAL RESULTS

19 Mar 2024 12:45:00 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 02/2024

11 Mar 2024 06:03:01 By Nasdaq GlobeNewswire

Virbac to take a leading position in Japan through the acquisition of Sasaeah

06 Mar 2024 02:20:00 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 01/2024

06 Feb 2024 09:54:53 By Nasdaq GlobeNewswire

VIRBAC: Annual revenue growth of +4.9% thanks to record fourth-quarter activity at +11.5%

17 Jan 2024 11:45:00 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 12/2023

08 Jan 2024 05:09:10 By Nasdaq GlobeNewswire

Outlook 2023-2024

19 Dec 2023 02:30:00 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 11/2023

07 Dec 2023 06:10:41 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 10/2023

09 Nov 2023 06:11:36 By Nasdaq GlobeNewswire

MAR Weekly Report_VIRBAC SA_October 30 to November 3 2023

06 Nov 2023 09:43:57 By Nasdaq GlobeNewswire

VIRBAC: Virbac acquired a majority stake in Globion, a leading Indian poultry vaccines specialist

02 Nov 2023 12:45:00 By Nasdaq GlobeNewswire

MAR Weekly Repport_VIRBAC SA_23 to 27 October 2023

30 Oct 2023 09:06:36 By Nasdaq GlobeNewswire

VIRBAC: revenue growth at the end of September at +2.8% at constant exchange rates and scope thanks to a strong activity rebound in the third quarter (+7.8% at constant exchange rates and scope)

23 Oct 2023 11:45:00 By Nasdaq GlobeNewswire

MAR Weekly Report_VIRBAC SA_16 to 20 October 2023

23 Oct 2023 05:23:16 By Nasdaq GlobeNewswire

VIRBAC: MAR Weekly Report_VIRBAC SA_9 to 13 October 2023

16 Oct 2023 05:24:30 By Nasdaq GlobeNewswire